Inocras Inc., a U.S.-based precision medicine company, today announced a strategic partnership with AimedBio, a South Korean ...

For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...

Many cancer-associated mutational signatures remain unexplained. Team CAUSE aims to connect DNA damage, mutational patterns, ...

Colorectal cancer is unique in having its own microbial "fingerprint," according to new research from the University of East Anglia. Colorectal cancer is the fourth most common cancer in the UK and ...

Researchers working on blood-based cancer screening have reached a threshold that could change how early-stage tumors are ...

Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...